DEEP SEQUENCING ANALYSES IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN THE COSMOS STUDY

被引：0
|
作者：
Fevery, B. [1 ]
Thys, K. [1 ]
Van Rossem, E. [1 ]
Verbinnen, T. [1 ]
Picchio, G. [2 ]
Aerssens, J. [1 ]
De Meyer, S. [1 ]
Beumont, M. [1 ]
Kurland, D. [2 ]
Lenz, O. [1 ]
机构：
[1] Janssen Infect Dis BVBA, Beerse, Belgium
[2] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30983-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0780
引用
收藏
页码：S623 / S623
页数：1
相关论文
共 50 条
  • [41] Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin
    Agarwal, Kosh
    Schultz, Michael
    Pianko, Stephen
    Bank, Leslie
    Collier, Jane
    George, Jacob
    Priest, Matthew
    Ryder, Stephen D.
    Burman, Blaire E.
    Cheent, Kuldeep
    Cramp, Matthew
    Forton, Daniel M.
    Leggett, Barbara A.
    MacQuillan, Gerry C.
    Ramji, Alnoor
    Richardson, Paul
    Ryan, Michael J.
    Stace, Nigel
    Zekry, Amany
    Zogg, Donald L.
    Barnes, Eleanor
    Brainard, Diana M.
    Massetto, Benedetta
    Chen, Frances
    McHutchison, John G.
    Subramanian, Mani
    Yoshida, Eric M.
    Foster, Graham R.
    HEPATOLOGY, 2016, 64 : 455A - 456A
  • [42] Sustained virologic response with daclatasvir plus sofosbuvir ± ribavirin (RBV) in chronic HCV genotype (GT) 1-infected patients who previously failed telaprevir (TVR) or boceprevir (BOC)
    Sulkowski, M. S.
    Gardiner, D. F.
    Rodriguez-Torres, M.
    Reddy, K. R.
    Hassanein, T.
    Jacobson, I.
    Lawitz, E.
    Lok, A. S.
    Hinestrosa, F.
    Thuluvath, P. J.
    Schwartz, H.
    Nelson, D. R.
    Everson, G. T.
    Eley, T.
    Wind-Rotolo, M.
    Huang, S. P.
    Gao, M.
    Mcphee, F.
    Hernandez, D.
    Sherman, D.
    Hindes, R.
    Symonds, W.
    Pasquinelli, C.
    Grasela, D. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 155 - 155
  • [43] Treatment Response to 12 Weeks of Simeprevir plus Sofosbuvir±Ribavirin (SMV plus SOF±RBV): A Meta-Analysis of 7 Studies With 715 HCV Genotype 1 (HCV-1) Patients
    Yee, Brittany E.
    Nghia Nguyen
    Lutchman, Glen
    Lim, Joseph K.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2015, 148 (04) : S1088 - S1089
  • [44] SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)
    Sulkowski, M. S.
    Gardiner, D. F.
    Rodriguez-Torres, M.
    Reddy, K. R.
    Hassanein, T.
    Jacobson, I.
    Lawitz, E.
    Lok, A. S.
    Hinestrosa, F.
    Thuluvath, P. J.
    Schwartz, H.
    Nelson, D. R.
    Everson, G. T.
    Eley, T.
    Wind-Rotolo, M.
    Huang, S. -P.
    Gao, M.
    McPhee, F.
    Hernandez, D.
    Sherman, D.
    Hindes, R.
    Symonds, W.
    Pasquinelli, C.
    Grasela, D. M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S570 - S570
  • [45] Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
    Dietz, Julia
    Schelhorn, Sven-Eric
    Fitting, Daniel
    Mihm, Ulrike
    Susser, Simone
    Welker, Martin-Walter
    Fueller, Caterina
    Daeumer, Martin
    Teuber, Gerlinde
    Wedemeyer, Heiner
    Berg, Thomas
    Lengauer, Thomas
    Zeuzem, Stefan
    Herrmann, Eva
    Sarrazin, Christoph
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6172 - 6181
  • [46] Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin
    Fevery, Bart
    Thys, Kim
    Van Eygen, Veerle
    Verbinnen, Thierry
    Van Rossem, Elizabeth
    Buelens, Annemie
    Aerssens, Jeroen
    Witek, James
    Picchio, Gaston
    De Meyer, Sandra
    Lenz, Oliver
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (02):
  • [47] SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3-4 (COHORT 2)
    Lawitz, E.
    Ghalib, R.
    Rodriguez-Torres, M.
    Younossi, Z. M.
    Corregidor, A.
    Sulkowski, M. S.
    DeJesus, E.
    Pearlman, B.
    Rabinovitz, M.
    Gitlin, N.
    Lim, J. K.
    Pockros, P. J.
    Fevery, B.
    Lambrecht, T.
    Ouwerkerk-Mahadevan, S.
    Callewaert, K.
    Symonds, W. T.
    Picchio, G.
    Lindsay, K.
    Beumont-Mauviel, M.
    Jacobson, I. M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S524 - S524
  • [48] DEEP SEQUENCING REVEALS ACCUMULATION OF VIRAL VARIANTS IN HCV GENOTYPE 1 INFECTED PATIENTS DURING RIBAVIRIN MONOTHERAPY
    Dietz, J.
    Mihm, U.
    Schelhorn, S-E
    Fitting, D.
    Susser, S.
    Welker, M. W.
    Teuber, G.
    Manns, M.
    Berg, T.
    Lengauer, T.
    Zeuzem, S.
    Herrmann, E.
    Sarrazin, C.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S540 - S541
  • [49] Efficacy of Sofosbuvir Plus Ribavirin with and without Pegylated Interferon-A in Patients with HCV Genotype 3A Infection
    Kamal, Mustafa
    Raja, Arsalan Jamil
    Ahmed, Tanveer
    Ali, Mashhood
    Rasheed, Faisal
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (07): : 2272 - 2274
  • [50] Virology analyses of HCV isolates from genotype 4 patients treated with simeprevir in combination with peginterferon/ribavirin in the Phase III RESTORE study
    Fevery, Bart
    Verbinnen, Thierry
    Peeters, Monika
    Zucchetto, Mauro
    Witek, James
    Jessner, Wolfgang
    De Meyer, Sandra
    Lenz, Oliver
    HEPATOLOGY, 2014, 60 : 1060A - 1060A
12345